The 15 Companies Defining Interventional Cardiology Today
The global interventional cardiology market is expected to surpass US$40 billion by the end of the decade. As ...
HighLife builds momentum in TMVR
HighLife has secured FDA Breakthrough Device designation for its trans-septal mitral valve replacement system, marking ...
EU TAVI Market 2026: Growth, Competition, and the Rise of New Challengers
The European transcatheter aortic valve implantation (TAVI) market continues to demonstrate robust growth in 2026, with ...
Xeltis passes halfway point in pivotal US trial, but regenerative vascular technology still has something to prove
Xeltis has exceeded 50% patient enrolment in the US pivotal trial evaluating aXess, its restorative vascular access ...
A Congress Full of Connection, Innovation and Perspective
What an absolute pleasure it was to meet so many people from across the electrophysiology community at EHRA 2026. From ...
Medtronic Backs Anteris with a $90M Strategic Investment
Medtronic has agreed to invest up to US$90 million in Anteris Technologies, supporting the continued development of the ...
.png)
Beating The Market - December 2025
The Next Battleground in Cardiology: Continuous Intelligence Editor’s Note: Cardiology is entering its most ...
Beating The Market - November 2025
The Money Is Still Moving and It’s Targeting the Heart Editor’s Note: AI isn’t just changing how we diagnose it’s ...
